1,035 hedge funds and large institutions have $34.9B invested in Biogen in 2021 Q3 according to their latest regulatory filings, with 72 funds opening new positions, 349 increasing their positions, 397 reducing their positions, and 124 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership:

less funds holding

Funds holding:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $

27% less call options, than puts

Call options by funds: $1.24B | Put options by funds: $1.7B

42% less first-time investments, than exits

New positions opened: 72 | Existing positions closed: 124

44% less funds holding in top 10

Funds holding in top 10: 2715 (-12)

Holders
1,035
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
15
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.24B
Puts
$1.7B
Net Calls
Net Calls Change

Top Buyers

1 +$195M
2 +$118M
3 +$113M
4
JP Morgan Chase
JP Morgan Chase
New York
+$70.9M
5
Amundi
Amundi
France
+$66.6M

Top Sellers

1 -$181M
2 -$117M
3 -$115M
4
Renaissance Technologies
Renaissance Technologies
New York
-$98.6M
5
Northern Trust
Northern Trust
Illinois
-$87.3M
Name Holding Trade Value Shares
Change
Change in
Stake
776
$236K
777
$235K
778
$232K
779
$232K
780
$230K
781
$230K
782
$230K
783
$230K
784
$230K
785
$229K
786
$227K
787
$227K
788
$226K
789
$226K
790
$226K
791
$226K
792
$226K
793
$225K
794
$225K
795
$225K
796
$224K
797
$220K
798
$220K
799
$216K
800
$216K